A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
Main Authors: | , , , , |
---|---|
Format: | Conference item |
Published: |
Association for Research in Vision and Ophthalmology (ARVO)
2018
|
_version_ | 1826276493697744896 |
---|---|
author | Halioua-Haubold, C Jolly, J Pinedo Villanueva, R Brindley, D MacLaren, R |
author_facet | Halioua-Haubold, C Jolly, J Pinedo Villanueva, R Brindley, D MacLaren, R |
author_sort | Halioua-Haubold, C |
collection | OXFORD |
description | |
first_indexed | 2024-03-06T23:14:47Z |
format | Conference item |
id | oxford-uuid:66c18840-e2e2-4bde-8b54-1dc777197735 |
institution | University of Oxford |
last_indexed | 2024-03-06T23:14:47Z |
publishDate | 2018 |
publisher | Association for Research in Vision and Ophthalmology (ARVO) |
record_format | dspace |
spelling | oxford-uuid:66c18840-e2e2-4bde-8b54-1dc7771977352022-03-26T18:33:56ZA dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)Conference itemhttp://purl.org/coar/resource_type/c_c94fuuid:66c18840-e2e2-4bde-8b54-1dc777197735Symplectic Elements at OxfordAssociation for Research in Vision and Ophthalmology (ARVO)2018Halioua-Haubold, CJolly, JPinedo Villanueva, RBrindley, DMacLaren, R |
spellingShingle | Halioua-Haubold, C Jolly, J Pinedo Villanueva, R Brindley, D MacLaren, R A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs) |
title | A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs) |
title_full | A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs) |
title_fullStr | A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs) |
title_full_unstemmed | A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs) |
title_short | A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs) |
title_sort | dual variable markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years qalys |
work_keys_str_mv | AT haliouahauboldc adualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys AT jollyj adualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys AT pinedovillanuevar adualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys AT brindleyd adualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys AT maclarenr adualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys AT haliouahauboldc dualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys AT jollyj dualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys AT pinedovillanuevar dualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys AT brindleyd dualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys AT maclarenr dualvariablemarkovmodeltoassessthepotentialbenefitsofchoroideremiagenetherapyonqualityadjustedlifeyearsqalys |